234 related articles for article (PubMed ID: 29870976)
21. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
[TBL] [Abstract][Full Text] [Related]
22. How to differentiate non-erosive reflux disease from functional heartburn.
Ke MY
J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
[TBL] [Abstract][Full Text] [Related]
23. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
25. Between GERD and NERD: the relevance of weakly acidic reflux.
de Bortoli N; Ottonello A; Zerbib F; Sifrim D; Gyawali CP; Savarino E
Ann N Y Acad Sci; 2016 Sep; 1380(1):218-229. PubMed ID: 27472432
[TBL] [Abstract][Full Text] [Related]
26. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
[TBL] [Abstract][Full Text] [Related]
27. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
[TBL] [Abstract][Full Text] [Related]
28. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy.
Iwakiri K; Sano H; Tanaka Y; Kawami N; Umezawa M; Futagami S; Hoshihara Y; Nomura T; Miyashita M; Sakamoto C
Digestion; 2010; 82(3):156-61. PubMed ID: 20588027
[TBL] [Abstract][Full Text] [Related]
30. Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?
Bashashati M; Hejazi RA; Andrews CN; Storr MA
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):335-41. PubMed ID: 24719900
[TBL] [Abstract][Full Text] [Related]
31. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
Winter JW; Heading RC
Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
[TBL] [Abstract][Full Text] [Related]
32. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring.
Iwakiri K; Kawami N; Sano H; Tanaka Y; Umezawa M; Kotoyori M; Hoshihara Y; Sakamoto C
J Gastroenterol; 2009; 44(7):708-12. PubMed ID: 19434361
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
[TBL] [Abstract][Full Text] [Related]
34. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease.
Frazzoni M; Savarino E; de Bortoli N; Martinucci I; Furnari M; Frazzoni L; Mirante VG; Bertani H; Marchi S; Conigliaro R; Savarino V
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):40-6. PubMed ID: 26122764
[TBL] [Abstract][Full Text] [Related]
35. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
36. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of esophageal acid exposure characteristics between reflux oesophagitis and non-erosive reflux diseases].
Wang K; Duan LP; Chen H; Xia ZW; Lin SR
Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):5-8. PubMed ID: 15769387
[TBL] [Abstract][Full Text] [Related]
38. [Pathophysiology and Treatment of PPI-resistant NERD].
Kawami N; Iwakiri K; Sakamoto C
Nihon Rinsho; 2015 Jul; 73(7):1197-201. PubMed ID: 26165080
[TBL] [Abstract][Full Text] [Related]
39. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
Xiong LS; Chen MH; Lin JK; Hu PJ
J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
[TBL] [Abstract][Full Text] [Related]
40. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
Lee KJ; Kwon HC; Cheong JY; Cho SW
Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
